27 May 2026
27 May 2026
The Doctors’ Lounges are spaces where medicine continues beyond medical consultations and treatment rooms at the Champalimaud Foundation.
Here, doctors gather to review cases, exchange perspectives, update medical records, catch up on their reading and think together.
It’s a place designed for concentration and care, where knowledge is constantly refined and expanded through everyday clinical practice.
It allows quiet moments to question and combine experience with research and study.
22 May 2026
The award recognises initiatives with a significant environmental, social and governance impact within the Portuguese market. Other nominees in this category included EDP, with the project Moonshot Next Best Action, Fundação MEO, with Música com Sentido, and NOS, with the project 5G enabler de uma indústria mais eficiente, developed in partnership with Sumol Compal.
22 May 2026
Redefining brain and mental health care through neurotechnologies – from Alzheimer’s to stroke, from Obsessive Compulsive Disorder to depression –, is the declared goal of the new Digital Neurotherapeutics Centre (DNTx), which opened its doors to the public at the Champalimaud Foundation (CF) on May 18th.
13 May 2026
The Champalimaud Foundation today announced the acquisition of a portfolio of T-cell receptor (TCR) programs, platform technologies, and associated assets from Medigene Immunotherapies GmbH, together with the execution of an exclusive license agreement with Helmholtz Munich for key chimeric co-stimulatory receptor technologies.
15 May 2026
With a career spanning leadership of some of Europe’s most influential biomedical research institutions, Otmar Wiestler joins the Champalimaud Foundation as Director of Champalimaud Science. An internationally recognised physician-scientist and research leader, he has played a central role in shaping large-scale scientific organisations, most notably as President of the Helmholtz Association and, prior to that, as Chairman and CEO of the German Cancer Research Center (DKFZ).
13 May 2026
The Vision Award Office is where ideas are shaped into global recognition.
It is here that the António Champalimaud Vision Award takes form, through careful preparation, collaboration and informed decision-making.
It is also home to the Ethics Committee, where research projects, in particular clinical studies, are supported and rigorously reviewed.
Here, decisions are not rushed. They are considered, debated and refined.
Because creating impact, and recognising it, requires the freedom to think deeply, to question, and to choose with responsibility.
08 May. 2026
Estamos a reforçar a nossa área financeira com a integração de um(a) Técnico(a) de Controlo de Gestão, responsável por apoiar as operações, a contabilidade, o controlo de gestão e a articulação com equipas internas e parceiros externos.
07 May 2026
Under the central theme of efficiency as a condition for a more sustainable, equitable and future-ready healthcare system, the event established itself as a forum for discussing concrete solutions, with proposals for more efficient use of public investment, improved incentives for professionals and patient-centred policies.
06 May 2026
Caring for patients is one of the Champalimaud Foundation’s core purposes, and the Radiotherapy Service supports that mission every day.
In a highly controlled environment, precise doses of radiation are targeted to treat different types of cancer.
Behind this precision is a dedicated team of specialised doctors, physicists, nurses and technicians, working together to ensure each treatment is both safe and effective.
Every detail matters. Every decision is guided by expertise, responsibility and care.